ILD Co-morbidites, CVD and metabolic diseases

PheWeb

ILD_CVDMETABOCOMORB

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries None

Check pre-conditions, main-only, mode, ICD version None

Check minimum number of events None

Include endpoints

I9_ISCHHEART

I9_CEREBVASC

I9_SECONDRIGHT

CARDIAC_ARRHYTM

OTHER_ILD_CVD_COMORB

E4_DIABETES

124888

ILD_CVDMETABOCOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to ILD Co-morbidites, CVD and metabolic diseases based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	121004	54924	66080
Unadjusted prevalence (%)	39.22	31.65	48.94
Mean age at first event (years)	56.89	55.83	57.78

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	4.67 [4.38, 4.99]	<1e-100	20845
15 years	0.01	3.04 [2.83, 3.28]	<1e-100	9320
5 years	0.00	4.65 [4.27, 5.06]	<1e-100	4375
1 year	0.00	21.94 [18.89, 25.49]	<1e-100	3776

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: ILD_CVDMETABOCOMORB – ILD Co-morbidites, CVD and metabolic diseases
GWS hits:

Survival analyses between endpoints

↥

Plot

before ILD Co-morbidites, CVD and metabolic diseases
after ILD Co-morbidites, CVD and metabolic diseases

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after ILD Co-morbidites, CVD and metabolic diseases

↥